Loxapine inhalation

Indication

Schizophrenia or bipolar disorder (NICE TA286 - terminated appraisal)

NICE TA286 - Loxapine Inhalation for treating acute agitation and disturbed behaviours associated with schizophrenia and bipolar disorder (terminated appraisal)

Black

Brand:

Nice TA:

286 (terminated)

Commissioning responsibility:

PbR excluded:

No

BNF chapter:

Central nervous system

Background

NICE is unable to recommend the use in the NHS because no evidence submission was received from the manufacturer of the technology

Recommendation

LSCMMG Recommendation:

Black

Reason for decision:

Not recommended for prescribing on the NHS in Lancashire & South Cumbria

Supporting documents:

Decisions of Lancashire local decision making groups

BwD	BP	CSR	EL	FW	GP	MB	WL
Pending	Black	Black	Pending	Black	Black	Black	Black

What do the colours mean?

Last Updated: 01 - Mar - 2018